Automated Desktop Immunoassay Analysers: The Tosoh AIA-CL solution

Automated Desktop Immunoassay Analysers: The Tosoh AIA-CL solution

Monday, February 5, 2024 3:30 PM to 4:00 PM · 30 min. (Asia/Dubai)

Information

This is a live in-person session, taking place at Cape Town room (Z1.C02). If you have any questions about the session, please send an email to Customer Success Team, IMCustomerSuccess@informa.com

Benchtop immunoassay analyzers are versatile instruments capable of performing a broad spectrum of biomarker assays with high analytical precision and accuracy. They offer a simplified and reliable approach, using either multi-test liquid vials or single-test cartridges. These devices are designed for use by healthcare professionals of varying expertise levels and cater to diverse clinical settings. Numerous manufacturers produce these benchtop/desktop immunoassay analyzers, each differing in size, level of automation, throughput, and performance!

In 2023, Tosoh Bioscience introduced the AIA-CL300, the smallest member of the AIA-CL family of automated chemiluminescence analyzers, also known as the “small giant” within the company. This compact yet powerful device offers more than 50 lyophilized assays/biomarkers in a single test format, along with a unique “twin-cup” design for long-term stability. It also features advanced automation to streamline daily routines, reduce hands-on time, and minimize human error. The AIA-CL300’s high assay sensitivity, repeatability, low sample volume requirements, and high usability make it an essential addition to any clinical laboratory. We invite you to explore its capabilities.”

Session Type
Non-CME
Conference Type
Product Showcases

Location

Tosoh International DMC BranchZ4.C20Tosoh Bioscience-Diagnostics is part of the Specialty division of Tosoh Corporation, a multi-national chemical company, present in 140 countries, employing 12,000 people. It is an acknowledged global leader in the diagnostic market and field of liquid chromatography. Tosoh has throughout the years demonstrated technological leadership in Immunochemistry, HPLC-based diabetes and Thalassemia screening as well as molecular testing solutions. These support the diagnosis and monitoring of life-threatening disease as diabetes, certain cancers and infections diseases among many others.  At the EuroMedLab 2023 Tosoh will launch the AIA®-CL300, its new Automated Chemiluminescent Enzyme Immunoassay Analyzer. This “Small Giant” is a flexible solutions to meet laboratories’ and hospitals’ specific needs. With its new design and compactness, AIA-CL300 sets new standards in terms of usability and result precision leading to better patient outcomes and treatments. The AIA-CL300 adds-on to the existing Tosoh Immunoassay Analyzer range, widely known for their reliability and analytical performance.

Log in